Company Filing History:

13 out of 1,149

Vertex Pharmaceuticals, Inc.

Years Active: 1998-2011

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7989498 - Inhibitors of IMPDH enzyme (2011-08-02),

2. 7442698 - Substituted heterocyclic compounds and methods of use (2008-10-28),

3. 7329681 - Inhibitors of IMPDH enzyme (2008-02-12),

4. 7115617 - Amino-substituted pyrimidinyl derivatives and methods of use (2006-10-03),

5. 7109215 - Compounds possessing neuronal activity (2006-09-19),

6. 7074789 - Kinase inhibitors (2006-07-11),

7. 6967214 - Inhibitors of IMPDH enzyme (2005-11-22),

8. 6939874 - Substituted pyrimidinyl derivatives and methods of use (2005-09-06),

9. 6881737 - Substituted triazinyl acrylamide derivatives and methods of use (2005-04-19),

10. 6653309 - Inhibitors of IMPDH enzyme technical field of the invention (2003-11-25),

11. 6541496 - Inhibitors of IMPDH enzyme (2003-04-01),

12. 6518291 - Inhibitors of IMPDH enzyme (2003-02-11),

13. 6495558 - Kinase inhibitors (2002-12-17),

14. 6344465 - Inhibitors of IMPDH enzyme (2002-02-05),

15. 6268384 - Compounds possessing neuronal activity (2001-07-31),

Title: The Inventive Journey of Perry M Novak

Introduction:

Perry M Novak, a talented inventor based in Milford, MA (US), has made significant contributions to the field of pharmaceuticals through his innovative work. With an impressive 19 patents to his name, Novak's research has focused on developing inhibitors of the IMPDH enzyme and substituted heterocyclic compounds for various therapeutic applications.

Latest Patents:

Novak's latest patents showcase his expertise in pharmaceutical innovation. One of his recent inventions includes compounds that inhibit the IMPDH enzyme, demonstrating promising potential as therapeutic agents for various conditions. Additionally, he has developed pyrimidine or pyridine carbamate compounds for the treatment of diseases such as inflammation, arthritis, organ transplant, and autoimmune disorders.

Career Highlights:

Currently employed at Vertex Pharmaceuticals, Inc., Novak continues to drive forward groundbreaking research in the pharmaceutical industry. His commitment to developing novel compounds and pharmaceutical compositions has earned him recognition as a leading inventor in his field. Novak's dedication to improving patient outcomes through innovative solutions is evident in his impressive patent portfolio.

Collaborations:

Throughout his career, Novak has collaborated with esteemed colleagues such as David M Armistead and Michael C Badia. Together, they have worked on various projects aimed at advancing drug discovery and development. These collaborations have led to the successful creation of patentable inventions that have the potential to make a significant impact on healthcare.

Conclusion:

In conclusion, Perry M Novak stands out as a visionary inventor who continues to push the boundaries of pharmaceutical innovation. His patented inventions reflect his passion for improving treatment options for a wide range of diseases and conditions. With a strong foundation in scientific research and a commitment to excellence, Novak's contributions to the field of pharmaceuticals are both inspiring and impactful.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.